Kenya: Kenya to Roll Out Long-Acting Injectable HIV Prep Lenacapavir By Jan 2026
[AllAfrica - Africa] - 16/07/2025
[Capital FM] Nairobi -- Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following its approval by the World Health Organization.
... Article published by "AllAfrica" (Africa), read more
For any information or claim on this article, see directly with the newspaper.
In Kenyan newspapers
Tache Assures MPs of Swift Action on Land Reservations
The Chief Executive Officer of the National Land Commission (NLC), Ms. Kabale Tache, on Friday appeared before the (…)
[Weekly Citizen] - 18/07/2025
LSK Reveals Growing Health Crisis Among Lawyers
LSK President Faith Odhiambo, urged legal practitioners to take charge of their health as they continue to uphold (…)
[Business Today] - 18/07/2025
Aviation Regulator Approves Konza City as First Drone Corridor to Boost Long-Range Operations
Kenya has approved the Konza technopolis as its first airspace dedicated entirely to drones, giving a green light to (…)
[Kenyan Wallstreet] - 9/07/2025
“I Don’t Have Much Money”: Maraga to Rely on Donations for 2027 Presidential Campaign
Chief Justice Emeritus David Maraga is banking on wellwishing Kenyans to fund his 2027 presidential campaign, saying (…)
[Nairobi Wire] - 17/07/2025
Bungoma Gen Z protesters tribulations, cough 20k bail each
Five suspects linked to looting and destruction of property during anti-government protests in Bungoma were released (…)
[Weekly Citizen] - 9/07/2025